Two Sigma Securities’s Minerva Surgical UTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-739
Closed -$2.43K – 3811
2023
Q3
$2.43K Sell
739
-268
-27% -$1.22K ﹤0.01% 2821
2023
Q2
$5.16K Buy
+1,007
New +$4.92K ﹤0.01% 2666

Two Sigma Securities's UTRS Position: Q4 2023 in Review

Two Sigma Securities sold out of Minerva Surgical (UTRS) in Q4 2023, closing a stake of 739 shares — an estimated $2.43K sold.

Two Sigma Securities first reported a position in UTRS in Q2 2023 and held it in 2 quarters. The position peaked at $5.16K in Q2 2023. 0 funds tracked by Wall St. Rank hold UTRS as of Q4 2023.

  • Two Sigma Securities reported no remaining Minerva Surgical position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Securities sold 739 Minerva Surgical shares in Q4 2023, an estimated $2.43K.
  • Two Sigma Securities first reported a position in Minerva Surgical in Q2 2023 and held it in 2 quarters.
  • Two Sigma Securities's Minerva Surgical position peaked at $5.16K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Minerva Surgical as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.